Introduction
Sjogren's syndrome is a multisystem disease that often occurs with connective tissue disorders.'"2 It may also be associated with auto-immune thyroid disease and myasthenia gravis.3 It is well known that thyroid disease can complicate idiopathic thrombocytopenic purpura (ITP) and more recently myasthenia gravis has been reported in a patient with chronic ITP. 4 However the case we describe appears to be the first report of a patient who developed ITP, auto-immune thyroid disease, Sj6gren's syndrome, and myasthenia gravis. This patient then re-presented with a rare parotid lymphoma associated with light chain amyloidosis.
Case report
A woman presented in 1967 at the age of 39 with idiopathic thrombocytopenic purpura which was successfully treated by splenectomy. In 1976 Sj6gren's syndrome was diagnosed after she developed dry eyes and a dry mouth. During the same year she underwent a partial thyroidectomy for a large goitre, histology of which showed Hashimoto's disease. In 1981 the patient developed diplopia followed by systemic weakness. A positive edrophonium test supported the diagnosis ofmyasthenia gravis and she responded well to oral prednisolone and pyridostigmine therapy.
In 1986 the patient noticed a painful increase in the size of her parotid and submandibular glands ( characterized by extensive confluent lymphoid proliferation and have been termed 'manifest malignant lymphoma'.7
It is not clear whether the high incidence of salivary gland lymphoma in Sj6gren's syndrome is increased further by the presence of other auto-immune diseases which are known to be associated with salivary BLL. This patient had auto-immune thyroid disease but there was insufficient evidence to diagnose systemic lupus erythematosus. Myasthenia gravis is associated with salivary gland periductal lymphocyte infiltrates but their significance in this condition is unclear.8
Parotid gland, muscle and gum biopsy showed amyloid infiltration in this patient which had not been present in rectal and jejunal biopsies two years earlier.
The onset ofamyloidosis seems to have occurred as the parotid gland enlarged presumably due to the lymphoma infiltration. The lymphoplasmacytoid lymphoma, and much of the amyloid stained immunohistochemically for lambda light chain, and lambda light chain paraprotein was found in the serum. Light chains can be amyloidogenic, a phenomenon most commonly observed with lambda light chains as in this patient.9 Review ofthe patient's thyroid histology with Figure 4 Immunohistochemical staining for light chain showing monoclonal population of lymphoplasmacytic infiltrate (x 24, immunoperoxidase method).
immunostaining showed an excess of lambda light chain containing plasma cells. This is compatible with studies of serum immunoglobulins in patients with autoimmune disease which have shown that organspecific auto-antibodies are predominantly of one light chain type, either lambda, or kappa in a given patient. Thus plasma cells in patients with Graves' disease and tissue plasma cell infiltrates in patients with Sjogren's syndrome demonstrate lambda chain bias.'0"12
The evolution of lymphoma is probably slow but early stages can be recognized by focal lymphocyte proliferations which demonstrate light chain bias immunohistochemically. The process of neoplastic change in B cells is not understood, but possible mechanisms may include hyper-responsiveness of B cells involved in auto-antibody production to growth factors." An alternative hypothesis is that neoplastic change may result from prolonged local anti-idiotypic response to pathogenic auto-antibody producing B cells within the target auto-immune organ. '2 
